XTNT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XTNT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Xtant Medical Holdings's Average Total Inventories for the three months ended in Dec. 2023 was $35.61 Mil. Xtant Medical Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was $10.97 Mil. Hence, Xtant Medical Holdings's Days Inventory for the three months ended in Dec. 2023 was 296.18.
The historical rank and industry rank for Xtant Medical Holdings's Days Inventory or its related term are showing as below:
During the past 13 years, Xtant Medical Holdings's highest Days Inventory was 361.33. The lowest was 248.90. And the median was 280.14.
Xtant Medical Holdings's Days Inventory increased from Dec. 2022 (224.57) to Dec. 2023 (296.18). It might indicate that Xtant Medical Holdings's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Xtant Medical Holdings's Inventory Turnover for the three months ended in Dec. 2023 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Xtant Medical Holdings's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.27.
The historical data trend for Xtant Medical Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 275.01 | 361.33 | 315.37 | 248.90 | 275.87 |
Xtant Medical Holdings Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 224.57 | 220.56 | 228.25 | 257.68 | 296.18 |
For the Medical Devices subindustry, Xtant Medical Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Xtant Medical Holdings's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Xtant Medical Holdings's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (17.285 | + | 36.885) | / | 2 ) | / | 35.836 | * | 365 |
= | 27.085 | / | 35.836 | * | 365 | ||||
= | 275.87 |
Xtant Medical Holdings's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (34.334 | + | 36.885) | / | 2 ) | / | 10.971 | * | 365 / 4 |
= | 35.6095 | / | 10.971 | * | 365 / 4 | ||||
= | 296.18 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings (AMEX:XTNT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Xtant Medical Holdings's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 10.971 | / | 35.6095 | |
= | 0.31 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Xtant Medical Holdings's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 35.6095 | / | 28.108 | |
= | 1.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Xtant Medical Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Kevin D Brandt | officer: VP & Chief Commercial Officer | 11621 RESEARCH CIRCLE, ALACHUA FL 32615 |
Lori D Mitchell-keller | director | 664 CRUISER LANE, BELGRADE MT 59714 |
Jonn R. Beeson | director | 664 CRUISER LANE, BELGRADE MT 59714 |
Scott C Neils | officer: Interim CFO | 664 CRUISER LANE, BELGRADE MT 59714 |
Mark A. Schallenberger | officer: Chief Operations Officer | 664 CRUISER LANE, BELGRADE MT 59714 |
Sean E Browne | officer: President and CEO | 664 CRUISER LANE, BELGRADE MT 59714 |
Stavros G. Vizirgianakis | director | 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016 |
Orbimed Rof Ii Llc | director, 10 percent owner | 601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022 |
Greg Jensen | officer: VP, Finance and Interim CFO | 664 CRUISER LANE, BELGRADE MT 59714 |
Ronald G. Berlin | officer: VP & Chief Operations Officer | 664 CRUISER LANE, BELGRADE MT 59714 |
Kathie J. Lenzen | officer: SVP Fiance & Admin. & CFO | 664 CRUISER LANE, BELGRADE MT 59714 |
Orbimed Advisors Llc | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Matthew Rizzo | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Michael Eggenberg | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Robert Mcnamara | director | C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 02-19-2021
By ACCESSWIRE AccessWire • 04-12-2019
By PRNewswire PRNewswire • 08-15-2020
By GuruFocus Research • 11-09-2023
By ACCESSWIRE AccessWire • 04-12-2019
By GuruFocus Research GuruFocus Editor • 03-19-2021
By GuruFocus Research GuruFocus Editor • 02-17-2021
By GuruFocus Research GuruFocus Editor • 03-04-2021
By GuruFocus Research GuruFocus Editor • 03-26-2021
By ACCESSWIRE AccessWire • 04-12-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.